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Abstract.  Nerve growth factor (NGF) mediates the 
phosphorylation of tyrosine hydroxylase in PC12 cells 
on two distinct peptide fragments,  separable by two- 
dimensional tryptic phosphopeptide mapping  (phos- 
phopeptides T1 and T3).  Phorbol diester derivatives 
capable of activating Ca+2/phospholipid-dependent pro- 
tein kinase (C-kinase) cause a  specific phosphorylation 
of peptide T3 in a dose-dependent,  saturable manner. 
Derivatives of the endogenous C-kinase activator di- 
acylglycerol, also cause the phosphorylation of tyro- 
sine hydroxylase on peptide T3.  The C-kinase inhibi- 
tors chlorpromazine and trifluoperazine inhibit the 
phorbol diester stimulated phosphorylation of site T3 
in a dose-dependent manner.  These agents inhibit the 
phosphorylation of T3 in response to NGE but have 
no effect on NGF's ability to cause T1 phosphory- 
lation. 
In a PC12 mutant deficient in cAMP-dependent pro- 
tein ldnase activity, NGF mediates the phosphorylation 
of tyrosine hydroxylase on peptide T3 but not on T1. 
We conclude that NGF mediates the activation of both 
the cAMP-dependent protein kinase and the C-kinase 
to phosphorylate substmte proteins.  These kinases can 
act independently to phosphorylate tyrosine hydroxy- 
lase, each at a different site, and each of which results 
in the enzyme activation.  A molecular framework is 
thus provided for events underlying NGF action. 
N 
"ERVE growth factor (NGF), ~ a protein growth hor- 
mone, is required for the survival and differentiation 
of sympathetic  and sensory neurons,  both in vivo 
and in vitro (23).  More recently,  requirements of NGF for 
the survival of adrenal chromaflin cell precursors (2) and for 
the differentiation  of central  nervous system  neurons  (see 
references  22  and  24)  have  been demonstrated.  PC12,  a 
clonal cell line derived from a rat pheochromocytoma, does 
not  require  NGF  for  survival,  yet responds  to  NGF  by 
differentiating  into  a  sympathetic  neuron-like  cell  (10). A 
wide range  of morphological and biochemical changes  ac- 
company NGF-induced neuronal  differentiation  (see refer- 
ences 9 and 46). Some of these include the extension of neu- 
ronal processes, elevation  of neurotransmitter-synthesizing 
enzyme  activities,  establishment  of  a  Na+-based  action 
potential,  and a decline of cell division. 
While the molecular mechanism of NGF action has been 
largely unknown, a number of schemes have been proposed 
to mediate NGF actions.  These include phospholipid or pro- 
tein methylation  (31, 37), phosphatidylinositol  turnover (20, 
39), elevation of cAMP, and a mobilization  of intracellular 
Ca  +2 (35).  We have  reported a  specific  enhancement of a 
number of protein phosphorylations within minutes of NGF 
treatment  of PC12 cells (12). Analysis of the total  phos- 
1.  Abbreviations  used  in  this  paper:  C-kinase,  Ca+2/phospholipid  - 
dependent protein kinase; NGF, nerve growth factor; PMA, phorbol-12- 
myristate-13-acetam. 
phoprotein patterns and in particular of ribosomal protein $6 
phosphorylation induced by a variety of agents,  suggested 
that NGF may activate cAMP-dependent protein kinase. An- 
other protein phosphorylation stimulated by NGF as well as 
by other agents  was that of tyrosine hydroxylase,  the rate- 
limiting enzyme for catecholamine neurotransmitter  biosyn- 
thesis.  NGF-induced phosphorylation of tyrosine hydroxy- 
lase results  in an activation  of the enzyme (8, 25). 
Tyrosine hydroxylase contains at least four potential  sites 
of phosphorylation (25). The use of two-dimensional  tryptic 
phosphopeptide mapping,  which separates  the sites, has re- 
cently allowed us to distinguish between different patterns of 
tyrosine  hydroxylase phospborylation  generated  in  PC12 
cells in response to various agents  (25).  We demonstrated 
that  NGF and cAMP elevation  each result in qualitatively 
similar but quantitatively distinct patterns of tyrosine hydrox- 
ylase phosphorylafion. The identity  of the kinases through 
which NGF is acting to pbosphorylate two peptide fragments 
within  tyrosine hydroxylase has been further investigated. 
By differentially  activating  and inhibiting  Ca+2/phospholip- 
id-dependent protein kinase (C-kinase) and cAMP-dependent 
protein kinase, we demonstrate that NGF-induced phosphor- 
ylation of tyrosine hydroxylase is independently  mediated by 
both of these kinases. 
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Materials 
The 2.5-S form ofNGF (13-NGF) was purified as described previously (26). 
Dibutyryl cAME all phorbol derivatives, chlorpromazine, trifluoperazine, 
and Nonidet P-40 were from Sigma Chemical Co. (St. Louis, MO).  1,2- 
dioctanoyl-3-glycerol and 1-oleoyl-2-acetyl-3-glycerol were obtained from 
Avanti  Polar Lipids (Birmingham,  AL).  Carrier-free H3  3zPO4 was ob- 
tained from New England Nuclear (Boston, MA). N-tosyI-L-pbenylalanine 
chloromethylketone-trypsin  was purchased from Worthington Biochemical 
Corp., Freehold, NJ. All other reagent grade chemicals were obtained from 
either Malinckrodt Inc. (Science Products Div., St. Louis, MO) or Fisher 
Scientific Co. (Pittsburgh, PA). 
Cell Culture 
Clone PC12 (10) and the mutant AI26-1B2  (40)  were grown in Dulbecco's 
modified Eagle's medium (41) containing 10% horse serum and 5 % fetal calf 
serum (KC Biologicals Inc., Lenexa, KS). Cultures were plated on 60-mm 
or 100-ram tissue culture dishes (Falcon Labware, Oxnard, CA) and kept 
at 37°C in 10%  CO2 and 90%  air. 
Labeling of Cells with 32p0, and Sample Processing 
These procedures were carried out according to the basic design described 
previously (12, 25).  Cells were grown to a density of <106 cells/60-mm 
dish at which time the growth medium was removed and the cells suspended 
in Eppendorf microtubes in Duibecco's modified Eagle's medium lacking 
phosphate but supplemented with 5 % fetal calf serum and 5 % horse serum, 
or Dulbocco's modified Eagle's medium containing only 0.09 mM phosphate 
(for experiments with diacylglycerols). After 1 h, carrier-free 32PO4 was 
then added to 500 laCi/ml if only gel eleetropboresis analysis was to be car- 
ried out or to 5 mCi/ml if phosphopeptide mapping was to be carried out. 
Various agents were added as indicated in the figure legends or in the text 
and the cells were incubated for 1-2 h. Since chlorpromazine or trifluopera- 
zinc were found to cause some cell lysis at the higher concentrations re- 
quired, experiments involving these inhibitors were carded out at 22°C, 
which circumvented this lysis problem. The cells were incubated at 220C, 
for 10 min before the addition of, and in the continual presence of the in- 
hibitors.  After incubations, the cells were pelleted by centrifugation at 
11,000 g for 30 s at 4"C. The pellet was then resuspended in ice cold lysis 
buffer (0.01 M NaP [pH 7.1], 0.1 M NaF, 0.24 M sucrose, 0.(31 M EDTA, 
and 1% Nonidet P-40) and allowed to stand for 1 rain on ice. The lysate 
was centrifuged for 3 min at 11,000 g to pellet the nuclei. The supernatant 
was then immediately solubilized by the addition of 1 vol twice-concen- 
trated solubilizing solution (Ix buffer contains 0.08 M Tris HC1 lpH 6.8], 
2%  SDS,  10%  glycerol, and 5%  freshly added 2-mercaptoethanol) and 
placement in a boiling water bath for 5 rain. 
Gel Electrophoresis and Autoradiography 
All samples were placed in a boiling water bath for 3 rain before electropho- 
resis.  One-dimensional eleetrophoresis was carried out in  10  or  17.5% 
acrylamide slab gels in 0.1% SDS as previously described (3). Autoradiog- 
raphy was carried out at -70°C with pretlashed Kodak X-Omat R film (21). 
Densitometry was carried out using the Chromoscan HI densitometer (Joyce 
Loebl, Division of Vickers Limited, Tyne and Wear,  England). 
Table L Stimulation  of Tyrosine Hydroxylase 
Phosphorylation by Phorbol  Derivatives 
Maximal 
Phorbol derivative  stimulation 
% 
413-phorbol-12-myristate-13-acetate (PMA, 200 nm)  100 
4[I-phorbol-12,13-dibenzoate (270 nm)  100 
413-phorbol-12-monomydstate (250 rim)  1 
4[3-phorbol (380 nrn)  0 
Cells were labeled with 32PO  4 in the presence or absence of the indicated 
phorbol derivatives.  Proteins were subjected to SDS PAGE, autoradiography, 
and densitometric  analysis  as described in Materials  and Methods. The in- 
crease in 32p-labeling of tyrosine hydroxylase was quantitated  as described in 
the legend to Fig.  1. 
Phosphopeptide Mapping of 1~yrosine  Hyroxylase 
Purification  of tyrosine  hydroxylase,  performic acid  oxidation,  tryptic 
digestion, and two-dimensional separation of resulting peptides were all 
carried out by a modification of the methods of Hunter and Sefton (14) ac- 
cording to McTigue, Cremins, and Halegoua (25). The four phosphopep- 
tides  (T1-T4) were  shown  to  be  tryptic-derived fragments of tyrosine 
hydroxylase by  immunoprecipitation and  two-dimensional gel  analyses 
(25). Autoradiograms were quantitated using a Joyce Loebl densitometer as 
before (25). 
Results 
C-Kinase-mediated Phosphorylation 
of ~rosine Hydroxylase 
Agents  that  have  been  shown  to  phosphorylate  tyrosine 
hydroxylase at tryptic phosphopeptide site T3 such as NGF, 
epidermal growth factor, cAMP, and K  + depolarization (25) 
have also been shown to result in an increased turnover  of 
phosphatidylinositol in responsive cells (34, 38). The result- 
ing liberation of diacyglycerol would be expected to result in 
C-kinase-directed protein phosphorylation.  Phorbol-12-my- 
ristate-13-acetate  (PMA), a direct activator of C-ldnase also 
causes the phosphorylation of tyrosine hydroxylase (Fig.  1; 
see also reference 25).  Cellular proteins labeled with 32po4 
in the presence or absence of increasing amounts of PMA 
were subjected to SDS PAGE and autoradiography.  Quantita- 
tion of specific tyrosine hydroxylase labeling as described in 
Materials  and  Methods  revealed  that  the  PMA-enhanced 
phosphorylation  of tyrosine  hydroxylase  was dose-depen- 
dent and saturable.  The maximal phosphorylation of tyro- 
sine  hydroxylase  by  PMA  in  various  experiments  ranged 
from between  1.5-  and  3.5-fold.  As  little as  2  nM  PMA 
caused  a  significant  phosphorylation  of the  enzyme  with 
maximal  phosphorylation  occurring  at  ,x,70 nM  PMA. 
These  dose-response  characteristics  are  compatible  with 
those  reported  for other  C-kinase-directed  protein  phos- 
phorylations  induced by PMA  in vivo  (see reference 43). 
The PMA-mediated increase in tyrosine hydroxylase phos- 
phorylation was seen within 1 rain of treatment and maximal 
phosphorylation was maintained for at least 2 h in the pres- 
ence of PMA. 
To further determine the specificity of the PMA-induced 
phosphorylation of tyrosine hydroxylase, other phorbol es- 
ters that have been shown to vary in their ability to activate 
C-kinase were examined. As documented in Table I, 413-phor- 
bol-12-monomyristate  and  413-phorbol  (each  at  over  200 
nM), which are ineffective in activating  C-kinase (6), did not 
result in an enhancement of tyrosine hydroxylase phosphory- 
lation. In contrast, 413-phorbol-12,13-dibenzoate,  which has 
been found to activate C-kinase to the same degree as PMA 
(6),  resulted  in the same degree of stimulation of tyrosine 
hydroxylase phosphorylation as PMA.  To demonstrate the 
site of phosphorylation within tyrosine hydroxylase, the cel- 
lular proteins from PC12 cells that had been 32P-labeled and 
PMA-treated or not, were subjected to SDS PAGE. The band 
migrating  at 60,000 D (Fig.  1 A), shown by immunoprecipi- 
tation and two-dimensional gel analysis to consist of tyrosine 
hydroxylase (12, 25), was cut out of the gel, extracted, and 
subjected to complete tryptic digestion and two-dimensional 
phosphopeptide  mapping  as  described  in  Materials  and 
Methods.  As  can be  seen  from the phosphopeptide  maps 
(Fig. 1 B), the increase in tyrosine hydroxylase phosphoryla- 
The Journal  of Cell Biology, Volume 103, 1986  888 Figure  1.  SDS PAGE and tryptic phosphopeptide mapping analysis of tyrosine hydroxylase phosphorylation stimulated by PMA and 
diacylglycerols. Cells were 32p-labeled in the presence or absence of the indicated agents. Cellular proteins were subjected to SDS 
PAGE  and autoradiography (A). Tyrosine hydroxylase was prepared and  subjected to tryptic phosphopeptide mapping (B)  all as 
described in Materials and Methods. (A) Lane 1, control, lane 2, +  PMA (200 nM); lane 3,  +  l-oleyl-2-acetyl-3-glycerol (0.3 raM); 
lane 4,  +  1,2-dioctanoyl-3-glycerol (0.3 mM).  (B)  Tryptic phosphopeptide map autoradiograms; DOG, 1,2-dioctanoyl-3-glycerol 
(0.3 raM). 
tion caused by PMA is due to an increase in phosphorylation 
on peptide T3 (see also reference 25). 
Since diacylglycerol  is the physiological activator of C-ki- 
nase, its ability to effect tymsine hydroxylas¢ phosphorylation 
was also examined. Cells were 32p-labeled in the presence 
or absence of 1-oleoyl-2-acetyl-3-glycerol  or 1,2-dioctanoyl- 
3-glycerol and the labeling of tyrosine hydroxylase assayed 
as described in Materials and Methods. These derivatives 
traverse the cell membrane and activate C-kinase (7, 16). As 
can be seen from the SDS polyacrylamide gel autoradiogram 
shown in Fig. 1, these agents resulted in an increased phos- 
phorylation of tyrosine hydroxylase. In  this  experiment, 
PMA,  1-oleoyl-2-acetyl-3-glycerol  and  1,2-dioctanoyl-3- 
glycerol each resulted in a 2.3-, 2-, and 4.5-fold stimulation 
of 32p incorporation into tyrosine hydroxylase, respectively. 
The greater potency of the 1,2,-dioctanoyl-3-glycerol com- 
pared with the 1-oleoyl-2-acetyl-3-glycerol agrees with pre- 
viously reported results (7). To determine which tryptic frag- 
ment of tyrosine hydroxylase is phosphorylated in response 
to  diacylglycerol, [32p]tyrosine  hydroxylase was  prepared 
from  cells  labeled  in  the  presence  or  absence  of  1,2- 
dioctanoyl-3-glycerol  and  subjected  to  two-dimensional 
phosphopeptide mapping as above.  As Fig.  1 B shows, this 
diacylglycerol  resulted in an increase in T3 phosphorylation. 
This pattern is similar to that induced by PMA (Fig.  1 B). 
To further assess whether the phosphorylation of tyrosine 
hydroxylase  at a site within T3 was directed by C-kinase, the 
drugs chlorpromazine and trifluoperazine,  each of which 
were reported to inhibit C-kinase in vitro and in vivo (17, 26, 
27, 44), were used. Cells were 32p-labeled in the presence of 
PMA and varying concentrations of either chlorpromazine 
or trifluoperazine. The 32P-labeling of tyrosine hydroxylase 
was quantitated as described in Materials and Methods. The 
inhibitors were found to block PMA-induced phosphoryla- 
tion of tyrosine hydroxylase in a  dose-dependent manner 
(Fig. 2). 
Inhibition of NGF-mediated T3 Phosphorylation 
The  above  results  demonstrated  that  phosphorylation of 
phosphopeptide T3 was directed by C-kinase in PC12 cells. 
It thus seems likely that the NGF-mediated phosphorylation 
of T3  occurs through activation of this kinase.  As Fig.  2 
shows, both chlorpromazine and trifluoperazine were able to 
inhibit  PMA-directed  phosphorylation  of  T3.  To  more 
directly determine if T3 phosphorylation by NGF was a re- 
sult of C-kinase activation, we tested the ability of these in- 
hibitors to block the T3 phosphorylation seen in response 
to NGE  Cells were labeled with 32po4 in the presence of 
NGF, with or without 0.4 mM chlorpromazine.  [32P]tyro- 
sine hydroxylase  was prepared and subjected to tryptic phos- 
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Figure 2.  Concentration  dependence  of trifluoperazine  and  of 
chlorpromazine-mediated  inhibition  of  PMA-stimulated  phos- 
phorylation  of tyrosine  hydroxylase.  Cells  were 32p-labeled in 
the presence or absence of  the indicated agents. Proteins were sub- 
jected to SDS PAGE (10% acrylamide),  autoradiography,  and 
densitometric analysis all as described in Materials and Methods. 
Stimulation  of tyrosine  hydroxylase  phosphorylation  by  PMA 
(200 nM) was determined as described in Fig.  1. The maximal 
phosphorylation of tyrosine hydroxylase by PMA  was  1.8-fold 
over the control. For each concentration of inhibitor, the stimula- 
tion seen by PMA was determined relative to the inhibitor alone. 
e, chlorpromazine; zx, trifluoperazine. 
phopeptide mapping analysis.  As can be seen in Fig.  3 B, 
NGF-mediated a threefold and D-fold increase in T1 and T3 
phosphorylation, respectively. In the experiment shown in 
Fig. 3, C and D chlorpromazine resulted in an 80% inhibi- 
tion of the T3 phosphorylation stimulated by NGE Greater 
than 90% inhibition has been observed in other experiments 
using  0.5  mM  chlorpromazine or 0.1  mM trifluoperazine 
(data not shown). There was, however, no reduction in the 
degree of NGF-stimulated TI phosphorylation by these in- 
hibitors (Fig.  3,  C and D).  These results indicate that the 
NGF-induced phosphorylation of T3 but not T1 results from 
the activation of C-kinase. 
Phosphorylation  of  Dj,  rosine Hydroxylase in 
cAMP-dependent Protein Kinase-deficient PC12 
We had  previously suggested that the phosphorylation of 
ribosomal protein $6 (12) and of tyrosine hydroxylase pep- 
tide T1 (25) in response to NGF resulted from an activation 
of  cAMP-dependent protein kinase. To more conclusively es- 
tablish that NGF mediated these phosphorylations through 
cAMP-dependent protein kinase, we examined the ability of 
NGF to elicit protein phosphorylations in mutant PC12 cells 
that are deficient in cAMP-dependent protein kinase activity 
(40). Cells were labeled with 32PO4 in the presence or ab- 
sence of NGE and the cellular proteins subjected to SDS 
PAGE as described in Materials and Methods. From densito- 
metric quantitation of the gel autoradiogram (shown in Fig. 
4 A, lanes I  and 2), a 2.5-fold increase in tyrosine hydroxy- 
lase phosphorylation as well as an increase in ribosomal pro- 
tein $6 phosphorylation were caused by NGF in wild-type 
PC12 cells (12). In the mutant line, NGF mediated a 1.5-fold 
increase in tyrosine hydroxylase phosphorylation, whereas 
no increase in the phosphorylation of ribosomal protein $6 
was observed (Fig. 4 A, lanes 3 and 4). Furthermore, addi- 
tion of dibutyryl cAMP or cholera toxin to the mutant cells 
did not result in an observable increase in the phosphoryla- 
tion  of any  cellular  proteins  (not  shown).  These  results 
confirm the reported deficiency of cAMP-dependent kinase 
in the mutant cells. 
To determine if the  NGF-mediated phosphorylation of 
Figure 3. Tryptic phosphopeptide mapping of tyrosine hydroxy- 
lase stimulated by NGF in the presence or absence of chlorproma- 
zinc. Cells were labeled with 32PO4 in the presence or absence of 
the  indicated  agents.  Tyrosine hydroxylase  was  prepared  and 
subjected to tryptic phosphopeptide mapping as described in Ma- 
terials  and Methods. A, control;  B,  +  NGF (50 ng/ml);  C,  + 
chlorpromazine (0.4 mM); D, + NGF (50 ng/ml) + chlorproma- 
zinc (0.4 mM). 
tyrosine hydroxylase at site T1 was due to cAMP-dependent 
protein kinase,  mutant cells were 32P-labeled in the pres- 
ence or absence of NGE The [32p]tyrosine hydroxylase was 
prepared and subjected to phosphopeptide mapping as de- 
scribed  in  Materials  and  Methods.  As  seen in  the phos- 
phopeptide maps,  NGF caused a multifold increase in the 
phosphorylation of T3 in both the mutant (Fig. 4 B) and the 
wild-type cells (Fig. 3, A and B). However the increase in 
T1 phosphorylation was  specifically lacking in the mutant 
cells. These results demonstrate that T1 phosphorylation in 
response to NGF is mediated by a cAMP-dependent protein 
kinase, whereas T3 phosphorylation induced by NGF can be 
attributed to a cAMP-independent mechanism, namely C-ki- 
nase activation. 
Discussion 
The  following conclusions  may  be  drawn  from the  data 
presented  above.  (a)  The  phosphorylation  of  tyrosine 
hydroxylase within tryptic-derived phosphopeptide T3 can 
be directed by C-kinase in PC12 cells. (b) The NGF-induced 
phosphorylation ofT3 is directed by C-kinase. (c) The NGF- 
induced  phosphorylation  of  T1  is  directed  by  cAMP- 
dependent protein kinase. (d) The action of  either kinase and 
resulting site-specific phosphorylation of tyrosine hydroxy- 
lase can occur independently in response to NGF. 
NGF mediates the phosphorylation of a number of  proteins 
in PC12 cells in a rapid and reversible manner (12). One of 
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ses of tyrosine hydroxylase phosphorylation stimulated by NGF in 
wild-type PC 12 and in cAMP-dependent protein kinase--deficient, 
mutant PC12. Ceils were 32p-labeled in the presence or absence 
of NGF. Proteins were subjected SDS PAGE and autoradiography 
(A). Tyrosine hydroxylase was prepared and subjected to tryptic 
phosphopeptide mapping (B). (A) Lane 1, wild-type control; lane 
2, wild-type +  NGF (50 ng/ml); lane 3, mutant control; lane 4, 
mutant +  NGF (50 ng/ml). (B) Mutant; CON, control; NGF,  + 
NGF (50 ng/ml). 
these  proteins,  tyrosine hydroxylase, is  a  multiply phos- 
phorylated protein  in which  site-specific phosphorylation 
can occur on each of four distinct peptide fragments in re- 
sponse to different agents (25).  NGF mediates the phos- 
phorylation of tyrosine hydroxylase on two fragments (T1 
and 13).  From an analysis of tyrosine hydroxylase phos: 
phorylation resulting from NGF treatment of PC12, we have 
determined that an activation of two kinases by NGF results 
in  the  phosphorylation  of tyrosine  hydroxylase.  This  is 
clearly indicated by the ability of NGF to elicit the phos- 
phorylation of each fragment independently (in the presence 
of site-specific inhibitors, see Figs. 3 and 4). 
The phosphorylation of tyrosine hydroxylase within pep- 
tide 13 is directed by C-kinase. This conclusion is supported 
by a variety of data. Specific activation of C-kinase by phor- 
bol diester derivatives or by diacylglycerol  derivatives result 
in 13 phosphorylation. Consistent with these results is the 
report of C-kinase-mediated phosphorylation and activation 
of tyrosine hydroxylase in vitro (1, 33). In addition, each of 
two C-kinase inhibitors, chlorpromazine or trifluoperazine, 
are able to block the phosphorylation of 13 by the phorbol 
ester, PMA. NGF treatment of PC12 cells and sympathetic 
neurons has been shown to cause phosphatidylinositol turn- 
over (20,  39).  Thus the resulting accumulation of diacyl- 
glycerol would activate C-kinase. We have shown that trifluo- 
perazine and chlorpromazine are each able to specifically 
block the phosphorylation of 13 by NGE This result addi- 
tionally leads to the conclusion that NGF mediates the phos- 
phorylation of 13 through C-kinase. However, since these 
compounds are also potent inhibitors of Ca+2/calmodulin - 
dependent protein kinase,  another kinase that phosphory- 
lates tyrosine hydroxylase in vitro (42, 45), the possibility 
that NGF uses this kinase to mediate T3 phosphorylation 
would have to be ruled out. The following evidence indicates 
that Ca+2/calmodulin-dependent protein kinase phosphory- 
lates tyrosine hydroxylase at phosphopeptide site T2, a site 
distinct from those phosphorylated in response to NGE The 
phosphorylation of I2 results from a membrane depolariza- 
tion-induced influx of Ca  +2 (25). The enhanced phosphory- 
lation of 12 under this condition is more sensitive to inhibi- 
tion  by  trifluoperazine  (median  infective  dose  10  ttM; 
Cremins and Halegoua, unpublished data) than is the PMA- 
stimulated phosphorylation of 13 (median infective dose 50 
ttM, from Fig. 2). Last, in vitro studies using purified com- 
ponents have indicated that the phosphorylation of tyrosine 
hydroxylase by Ca+2/calmodulin-dependent protein kinase 
occurs at a site distinct from that phosphorylated by C-kinase 
(1, 42). 
NGF treatment of PC12 cells results in the stimulation of 
cAMP-dependent protein kinase activity. This conclusion is 
supported by a variety of data. NGF causes a rise in cAMP 
levels in PC12 cells (35).  NGF and agents that raise cAMP 
concentrations result in qualitatively similar patterns of pro- 
tein phosphorylation in PC12 cells as analyzed by one- and 
two-dimensional gel electrophoresis (12). In the same study, 
additivity experiments that were performed using NGF and 
a number of other agents that result in ribosomal protein $6 
phosphorylation, indicated that only the NGF plus cAMP 
combination is not additive. NGF and elevators of cAMP re- 
sult in the phosphorylation of tyrosine hydroxylase within 
phosphopeptide T1 (13, 25). T1 phosphorylation in response 
to NGF occurs even in the presence of C-kinase inhibitors 
(Fig. 3). cAMP-dependent protein kinase mediates the phos- 
phorylation of tyrosine hydroxylase in vitro (15). In a PC12 
mutant, deficient  in cAMP-dependent protein kinase activity, 
NGF is unable to mediate the phosphorylation of either T1 
or of ribosomal protein $6. 
An apparent  inconsistency exists between some of our 
results and those of  others using an in vitro approach to study 
tyrosine hydroxylase  phosphorylation. Although our data in- 
dicate that cAMP-dependent protein kinase and C-kinase 
mediate the phosphorylation of distinct sites  on  tyrosine 
hydroxylase in PC12 cells, the sites phosphorylated by these 
kinases in vitro were reported to be identical (1, 42).  One 
possible explanation may lie in the different phosphopeptide 
mapping  systems used.  We have previously shown that a 
separation  of all  phosphopeptides  derived  from  tyrosine 
hydroxylase  is dependent upon the use of  the appropriate sys- 
tem for two-dimensional separation (25).  Alternatively, the 
sites within tyrosine hydroxylase  that are accessible to phos- 
phorylation by the various kinases in vitro may be different 
from those accessible in living cells. Within this latter con- 
text, C-kinase activation in vivo may result in the activation 
of another kinase which phosphorylates T3, and hence C-ki- 
nase may be indirectly responsible for 13 phosphorylation. 
An outcome of the present studies is the demonstration 
that NGF can independently stimulate two different kinase 
pathways. The phosphorylation of T1 by cAMP-dependent 
protein kinase appears to be independent of phosphatidyl- 
inositol turnover and C-kinase activation because it occurs 
even in the presence of C-kinase inhibitors. This is further 
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sitol  turnover and/or C-kinase  activation and a  resulting 
phosphorylation of I3, do not mediate an increased phos- 
phorylation of  Tl (25). In contrast, 13 phosphorylation in re- 
sponse to NGF appears to be only partially dependent upon 
cAMP-dependent protein kinase activation. Whereas cAMP 
elevation results in I3 phosphorylation in wild-type cells 
(25) but does not do so in a PC12 mutant deficient in cAMP- 
dependent protein kinase, NGF is still able to mediate 13 
phosphorylation in the mutant cells. It is possible that cAMP- 
dependent protein kinase may phosphorylate sites in both T1 
and 13. However, cAMP-dependent protein kinase activation 
results  in only T1  phosphorylation in adrenal chromatfin 
cells (site E in reference 13; see reference 25). Thus a more 
likely and interesting alternative is that elevation of cAMP- 
dependent protein kinase activity in PC12 cells  leads in- 
directly to the activation of C-kinase. Consistent with this in- 
terpretation is the finding that CAMP elevation in PC12 cells 
results in phosphatidylinositol turnover (38). 
A framework for the molecular events underlying NGF ac- 
tion emerges from existing data. NGF may activate C-kinase 
through two distinct but converging pathways.  Both path- 
ways involve increased turnover of phosphatidylinasitol, one 
through a more direct means (i.e., NGF receptor-G protein 
interaction)  and  the  other  indirectly  through  cAMP- 
dependent protein kinase activation. The resulting accumu- 
lation of diacylglycerol would activate C-kinase and thus 
result in the phosphorylation of substrate proteins such as 
tyrosine hydroxylase (within 13) and others. One candidate 
for the putative G-protein involvement is the proto-oncogene 
product, ras p21. A  monoclonal antibody directed against 
and inhibitory for ras p21 proteins inhibit NGF-directed neu- 
rite extension  (11), whereas  activated ras  protein mimics 
NGF action on PC12 cells (4, 29). The pathway for the acti- 
vation of cAMP-dependent protein kinase by NGF has also 
not yet been elucidated.  NGF caused a  small rise in the 
cAMP level in PC12 cells (35) and sympathetic neurons (28, 
36). However,  stimulation of adenylate cyclase by NGF has 
not been detectable, although NGF potentiates cAMP eleva- 
tion by other agents (32).  It also remains a possibility that 
cAMP phosphodiesterase activity is affected by NGE The 
stimulation of cAMP-dependent protein kinase would result 
in the phosphorylation of tyrosine hydroxylase (within T1), 
ribosomal protein $6,  and others. The analysis of tyrosine 
hydroxylase phosphorylation should continue to provide a 
useful means of assessing the differential activation of multi- 
ple cellular kinases in PC12 cells. 
What are the cellular consequences of  the activation of two 
protein kinases by NGF? In one case, two major kinase ac- 
tivities converge to phosphorylate a common substrate, tyro- 
sine  hydroxylase,  at  two  sites.  Phosphorylation  at  each 
unique site has been shown to result in the enzyme activation 
(13, 25). The significance of tyrosine hydroxylase activation 
by  NGF  and  the  resulting increased catecholamine neu- 
rotransmitter synthesis has been discussed (8, 25).  Activa- 
tion of these kinases may mediate other NGF actions. For 
example, NGF induces the synthesis of a number of enzymes 
and other proteins. The induction of the proto-oncogenefos 
product by NGF has been suggested to occur via activation 
of C-kinase (18). The induction of ornithine decarboxylase 
by NGF occurs even in mutant PC12 cells deficient in cAMP- 
dependent protein kinase (40).  Furthermore, ornithine de- 
carboxylase has been shown to be induced by C-kinase acti- 
vators (30). A major morphological change induced by NGF 
is the extension of neuronal processes. NGF-mediated neu- 
rite outgrowth has been suggested to occur via a combination 
of rapid,  short  term events  and long term transcription- 
dependent events (see reference 5). The elevation of cAMP 
and Ca  ++ mobilization have also been suggested to play a 
role  in  NGF-induced  neurite  extension  (35),  possibly 
through phosphatidylinositol turnover (38, 39). We have fur- 
ther  determined that  neurite  extension is  preceded  by  a 
change in the phosphorylation and distribution of vinculin 
and focal adhesions by NGF (S.  Halegoua, manuscript in 
preparation). The role of  this and other protein phosphoryla- 
tions, directed by NGF-stimulated protein kinases,  in the 
process of neurite extension is being actively investigated. 
Increased protein phosphorylation in response to NGF 
may result not only from the activation of cAMP-dependent 
and C-kinases. A third distinct kinase stimulated by NGF has 
been  observed  in  cytoskeletal preparations,  which  phos- 
phorylates a cytoskeletal protein of 230 kD (19). In addition, 
protein  phosphorylation caused  by  NGF  at  a  somewhat 
longer time course has been previously reported (47).  It is 
further likely that some actions of NGF are elicited by other 
cellular effectors either independently or in concert with pro- 
tein kinases. 
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